Symbol | Name | Grade | Market Cap | Country |
---|---|---|---|---|
LLY | Eli Lilly and Company | 53.4 | ¤723,276 | US |
UNH | UnitedHealth Group Incorporated | 52.7 | ¤450,826 | US |
ABBV | AbbVie, Inc. | 49.8 | ¤320,084 | US |
PFE | Pfizer Inc. | 27.8 | ¤158,844 | US |
AMGN | Amgen Inc. | 52.0 | ¤145,523 | US |
Symbol | Name | Grade | Market Cap | Country |
---|---|---|---|---|
ASRT | Assertio Holdings, Inc. | 43.0 | ¤104 | US |
ZYXI | Zynex, Inc. | 41.8 | ¤392 | US |
VYGR | Voyager Therapeutics, Inc. | 88.2 | ¤496 | US |
OSUR | OraSure Technologies, Inc. | 59.2 | ¤508 | US |
ZYME | Zymeworks Inc. | 20.0 | ¤767 | US |
Symbol | Name | Grade | Times* | Country |
---|---|---|---|---|
AMGN | Amgen Inc. | 52.0 | 54 | US |
UNH | UnitedHealth Group Incorporated | 52.7 | 46 | US |
GILD | Gilead Sciences, Inc. | 54.8 | 43 | US |
WAT | Waters Corporation | 52.7 | 41 | US |
RMD | ResMed Inc. | 64.3 | 40 | US |
REGN | Regeneron Pharmaceuticals, Inc. | 51.3 | 38 | US |
IDXX | IDEXX Laboratories, Inc. | 63.5 | 37 | US |
UTHR | United Therapeutics Corporation | 79.3 | 34 | US |
SYK | Stryker Corporation | 62.7 | 29 | US |
GMED | Globus Medical Inc Class A | 49.5 | 28 | US |
Average Market Cap | ¤69,760 |
Median Market Cap | ¤7,022 |
Avg. 3 Mo. Dollar Vol. | ¤315,531,259 |
Avg. 3 Mo. Trading Vol. | 2,795,436 |
Last Rebalance Date | 08/21/2023 |
Companies Replaced | 10 |
Biggest Industry Increase | Pharmaceuticals: Major |
Biggest Industry Decrease | Biotechnology |
Companies Overlapping S&P 500 | 15 |
Trailing P/E Ratio (12 Mo.) | 25.8 |
Forward P/E Ratio (12 Mo.) | 21.1 |
Price/Book Ratio | 4.0 |
Avg. Revenue Chg. - 3 Yr | 46.1% |
Avg. Op. Income Chg. - 3 Yr. | 23.1% |
Avg. EPS Growth - 3 Yr. | 6.2% |
Avg. EPS Growth - 1 Yr. | 10.3% |
Avg. Operating Margin | 21.2% |
Avg. LT Debt to Total Capital | 42.0% |
Avg. Return on Equity | 20.8% |
Dividend Yield | 0% |
MarketGrader Health Care Index | 55.57 |
United States Of America | 95.0% |